News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Caryn Lerman: HPV16 Causes More Than Half of Cervical Cancer Cases
Caryn Lerman/LinkedIn
Aug 21, 2025, 14:21

Caryn Lerman: HPV16 Causes More Than Half of Cervical Cancer Cases

Caryn Lerman, Director at USC Norris Comprehensive Cancer Center, shared on LinkedIn:

“HPV16 causes more than half of cervical cancer cases and roughly 90% of HPV-linked throat cancers.

It can be neutralized with the preventive vaccine Gardasil-9, but only if vaccination occurs prior to HPV exposure.

Published in the Journal of ImmunoTherapy of Cancer , USC Norris member Dr. W. Martin Kast and Ruben Prins, a post-doctoral candidate in the Kast laboratory, uncovered how cervical and throat cancers linked to the human papillomavirus evade the immune system, opening the door to new treatment strategies. Learn more about this phenomenal research here.”

Proceed to the video attached to the post.

cancer Caryn Lerman cervical cancer HPV16 Journal of ImmunoTherapy of Cancer OncoDaily Oncology Ruben Prins W. Martin Kast
Special Coverage
Voices
Aug 21, 2025, 14:21
Caryn Lerman: HPV16 Causes More Than Half of Cervical Cancer Cases
Voices
Aug 21, 2025, 14:18
Svetlana Nikic: Changing the Game in Precision Oncology Education
Voices
Aug 21, 2025, 14:07
NCI Awards $4.5M to Myosin Therapeutics for Groundbreaking Glioblastoma Clinical Trial
Voices
Aug 21, 2025, 14:06
Krishna Soujanya Gunturu: The Hartford HealthCare Cancer Institute is Expanding its Clinical Research Team
Voices
Aug 21, 2025, 14:01
IU Simon Cancer Center Engages 1,800 Fairgoers at Indiana State Fair
Voices
Aug 21, 2025, 13:39
Boston City Councilor Visited Dana-Farber to Learn About EQUAL Study
Voices
Aug 21, 2025, 13:35
David Skorton: $2 Billion Loss - NIH Funding Crisis Hits Clinical Trials
Insight
Aug 21, 2025, 13:21
Harpreet Singh: FDA’s New Draft Guidance on Radiopharmaceutical Dosing Is Here
Voices
Aug 21, 2025, 13:19
Miriam Mutebi: Why We Need to Expand Research in Palliative and Supportive Care
Insight
Aug 21, 2025, 13:16
Javier Martin-Broto: Collaborative Study Supports Mifamurtide Use in Osteosarcoma Treatment
Voices
Aug 21, 2025, 12:57
How Cancer-Induced Nerve Injury Contributes to Immunotherapy Resistance - MD Anderson Cancer Center
Voices
Aug 21, 2025, 12:34
Nirmala Bhoo Pathy: First-Ever Workshop on Patient and Financial Navigation